PubRank

Juan I Esteban

Author PubWeight™ 15.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. Gastroenterology 2006 1.31
2 International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C. J Hepatol 2005 1.30
3 HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project). Gastroenterology 2007 1.06
4 Ultra-deep pyrosequencing detects conserved genomic sites and quantifies linkage of drug-resistant amino acid changes in the hepatitis B virus genome. PLoS One 2012 1.06
5 Specific cleavage of hepatitis C virus RNA genome by human RNase P. J Biol Chem 2002 1.00
6 Utility of week-4 viral response to tailor treatment duration in hepatitis C virus genotype 3/HIV co-infected patients. AIDS 2007 0.92
7 Structural analysis of hepatitis C RNA genome using DNA microarrays. Nucleic Acids Res 2004 0.88
8 Response-guided therapy for chronic hepatitis C virus infection in patients coinfected with HIV: a pilot trial. Clin Infect Dis 2009 0.85
9 Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study. BMC Gastroenterol 2012 0.84
10 Transmission of low-density hepatitis C viral particles during sexually transmitted acute resolving infection. J Med Virol 2008 0.82
11 Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesis. PLoS One 2013 0.81
12 Early monitoring of ribavirin serum concentration is not useful to optimize hepatitis C virus treatment in HIV-coinfected patients. Antivir Ther 2007 0.81
13 Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients. Antivir Ther 2006 0.81
14 Identification of host and viral factors involved in a dissimilar resolution of a hepatitis C virus infection. Liver Int 2013 0.80
15 Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40. Antiviral Res 2007 0.78
16 Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen. J Antimicrob Chemother 2008 0.78
17 Quasispecies dynamics in hepatitis C liver transplant recipients receiving grafts from hepatitis C virus infected donors. J Gen Virol 2015 0.78
18 Abacavir coadministration does not interfere with the suppressive activity of ribavirin in an HCV replicon system. Antivir Ther 2011 0.75